Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
Essex enriches and complements Emmes’ services
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
The move will add new global talent to Cytel’s Strategic Consulting group
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
The Trial, the first of its kind in Israel, recently obtained approval from the Israeli Ministry of Health and is preparing for participant recruitment.
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Subscribe To Our Newsletter & Stay Updated
